FDA Approves Medtronic 780G Artificial Pancreas System
FDA approved the Medtronic 780G artificial pancreas system, providing automatic adjustments and corrections to blood-sugar levels.
INSULIN Act to Help Achieve Insulin Affordability
Breakthrough T1D supports the INSULIN Act and encourages advocates to contact their Senators and urge them to support this legislation…
Breakthrough T1D Collaboration Leads to Next-Generation Cell Therapy Research
Aspect and Novo Nordisk announce a partnership, using Aspect’s bioprinting technology and Novo Nordisk’s expertise, to develop treatments for diabetes.
Ketones, diabetic ketoacidosis, and type 1 diabetes
What do ketone levels mean with type 1 diabetes (T1D)? How do ketones cause diabetic ketoacidosis (DKA)? Breakthrough T1D is…
Breakthrough T1D Advocates, A Voice for the T1D Community
Breakthrough T1D Advocates use the most powerful tools they have—their own personal stories—to raise awareness and power progress for the…
A Bittersweet Goodbye for Breakthrough T1D Champion Cynthia Rice
JDRF’s Chief Mission Strategy Officer will leave behind quite a legacy once she steps down from her role at Breakthrough…
Clinical Trials: The Ultimate Form of T1D Advocacy
Meet two type 1 diabetes (T1D) clinical trial participants who are helping improve lives and getting us closer to cures,…
Breakthrough T1D Advocates Unite in D.C. to Fight for the T1D Community
The Federal Government is one of Breakthrough T1D’s most important partners in advancing research to better treat, prevent, and ultimately…
Breakthrough T1D Presents Award Honoring Trailblazer Mary Tyler Moore
The inaugural award goes to Senator Susan Collins (R-ME), Senator Jeanne Shaheen (D-NH), and Rep. Diana DeGette (D-CO).
Visionary Women Talk Balancing Career, Health, and T1D
Our March TypeOneNation virtual summit featured a group of incredible women with type 1 diabetes (T1D) sharing their stories about…
